Delivery Order SPE2DB22D2005-SPE2DB24FJJP8
Award Date 3/6/24
Potential Completion Date 3/7/24
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product, and has a ceiling value of $1,352.72. The contract is a firm fixed price delivery order with an ultimate completion date of April 2, 2024. This award is associated...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,599.42, is for the delivery of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement. The contract has an ultimate completion date of November 20, 2023 and was awarded on November 17, 2023. This award...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564184299 - NAROPIN 0.5% 150 MG/30 ML VIAL 30ML. The $5,266.26 contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $1,406.70 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the supply of NAROPIN 0.5% 100 MG/20 ML VIAL 20ML, a prescription pharmaceutical product. The award has an ultimate completion date of May 29, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,288.04 firm fixed-price delivery order covers the supply of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product, with a performance period through November 2024. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NAROPIN 0.2% 40 MG/20 ML VIAL 20ML, a medical product, with a ceiling value of $1,903.47 and a performance period ending on January 14, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a local anesthetic medication. The contract has a ceiling value of $4,450.59 and is a firm fixed price delivery order, with a completion date of August 13, 2024. The contract is not set aside for any special business category. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs)...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price, valued at $2,665.86, for the supply of a pharmaceutical product, NAROPIN 0.5% 150 MG/30 ML VIAL 30ML. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 150 mg/20 ml vials of the pharmaceutical product NAROPIN 0.75% in support of military treatment programs and facilities. The order has a potential value of $1,580.06 and a completion date of January 24, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,627.60 and is for the delivery of the drug NAROPIN 0.5% 100 MG/20 ML VIAL 20ML. The contract is a firm-fixed price, delivery order type and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...